Jane Street’s Alimera Sciences ALIM Stock Holding History

Jane Street’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,895	Closed	-$93.9K	–	10658
2024 Q2	$93.9K	Buy	+16,895	New	+$60K	﹤0.01%	8751
2018 Q4	–	Sell	-769	Closed	-$11K	–	5897
2018 Q3	$11K	Buy	+769	New	+$11.7K	﹤0.01%	4993
2016 Q3	–	Sell	-1,326	Closed	-$24K	–	4668
2016 Q2	$24K	Buy	+1,326	New	+$35.3K	﹤0.01%	3979
2014 Q4	–	Sell	-900	Closed	-$73K	–	3137
2014 Q3	$73K	Sell	900 -325	-27%	-$27.8K	﹤0.01%	2391
2014 Q2	$110K	Sell	1,225 -8,755	-88%	-$777K	﹤0.01%	2346
2014 Q1	$1.18M	Buy	+9,980	New	+$969K	0.01%	838

Jane Street's ALIM Position: Q3 2024 in Review

Jane Street sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 16,895 shares — an estimated $93.9K sold.

Jane Street first reported a position in ALIM in Q1 2014 and held it in 6 quarters. The position peaked at $1.18M in Q1 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Jane Street reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Jane Street sold 16,895 Alimera Sciences shares in Q3 2024, an estimated $93.9K.
Jane Street first reported a position in Alimera Sciences in Q1 2014 and held it in 6 quarters.
Jane Street's Alimera Sciences position peaked at $1.18M in Q1 2014.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.